{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:56:17Z","timestamp":1769504177154,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.det.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:25:33Z","timestamp":1555633533000},"page":"269-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Merkel Cell Carcinoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Christine","family":"Cornejo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.det.2019.03.001_bib1","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","article-title":"Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system","volume":"23","author":"Harms","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.det.2019.03.001_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12105-018-0898-2","article-title":"Update on Merkel cell carcinoma","volume":"12","author":"Tetzlaff","year":"2018","journal-title":"Head Neck Pathol"},{"issue":"12","key":"10.1016\/j.det.2019.03.001_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41571-018-0103-2","article-title":"The biology and treatment of Merkel cell carcinoma: current understanding and research priorities","volume":"15","author":"Harms","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.det.2019.03.001_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ijc.31860","article-title":"Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France","volume":"144","author":"Kieny","year":"2018","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.det.2019.03.001_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamadermatol.2014.124","article-title":"Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010","volume":"150","author":"Youlden","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.det.2019.03.001_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","article-title":"Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features","volume":"58","author":"Heath","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2019.03.001_bib7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1200\/JCO.2010.31.1704","article-title":"High levels of antibodies against Merkel cell polyomavirus identify a subset of patients with Merkel cell carcinoma with better clinical outcome","volume":"29","author":"Touze","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.det.2019.03.001_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bjd.14313","article-title":"Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma","volume":"174","author":"Samimi","year":"2016","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.det.2019.03.001_bib9","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/cncr.30475","article-title":"Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: a prospective validation study","volume":"123","author":"Paulson","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.det.2019.03.001_bib10","series-title":"AJCC cancer staging manual","first-page":"549","article-title":"Merkel cell carcinoma","author":"Bichakjian","year":"2017"},{"issue":"5","key":"10.1016\/j.det.2019.03.001_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaad.2010.02.056","article-title":"Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system","volume":"63","author":"Lemos","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2019.03.001_bib12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.6004\/jnccn.2018.0055","article-title":"Merkel cell carcinoma, version 1.2018 clinical practice guidelines in oncology","volume":"16","author":"Bichakjian","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.det.2019.03.001_bib13","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1200\/JCO.2005.02.329","article-title":"Merkel cell carcinoma: prognosis and treatment of patients from a single institution","volume":"23","author":"Allen","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.det.2019.03.001_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bjd.14240","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases","volume":"174","author":"Gunaratne","year":"2016","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2019.03.001_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.suronc.2017.10.005","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma: the Mayo Clinic experience of 150 patients","volume":"27","author":"Sims","year":"2018","journal-title":"Surg Oncol"},{"issue":"12","key":"10.1016\/j.det.2019.03.001_bib16","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/hed.25345","article-title":"Systematic review of sentinel lymph node biopsy in Merkel cell carcinoma of the head and neck","volume":"40","author":"Karunaratne","year":"2018","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.det.2019.03.001_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hed.24527","article-title":"Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck","volume":"39","author":"Strom","year":"2017","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.det.2019.03.001_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archderm.142.6.685","article-title":"Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature","volume":"142","author":"Gupta","year":"2006","journal-title":"Arch Dermatol"},{"issue":"18","key":"10.1016\/j.det.2019.03.001_bib19","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1002\/cncr.29452","article-title":"Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma","volume":"121","author":"Smith","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.det.2019.03.001_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2013.11.031","article-title":"Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma","volume":"70","author":"Iyer","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2019.03.001_bib21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.6004\/jnccn.2016.0134","article-title":"Merkel cell carcinoma: a population analysis on survival","volume":"14","author":"Sridharan","year":"2016","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.det.2019.03.001_bib22","doi-asserted-by":"crossref","first-page":"489536","DOI":"10.1155\/2014\/489536","article-title":"Prognostic significance of sentinel lymph node mapping in Merkel cell carcinoma: systematic review and meta-analysis of prognostic studies","volume":"2014","author":"Sadeghi","year":"2014","journal-title":"Biomed Res Int"},{"issue":"5","key":"10.1016\/j.det.2019.03.001_bib23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/annonc\/mdw035","article-title":"Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy","volume":"27","author":"Servy","year":"2016","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.det.2019.03.001_bib24","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1245\/s10434-011-1662-y","article-title":"Recurrence and survival in patients undergoing sentinel lymph node biopsy for Merkel cell carcinoma: analysis of 153 patients from a single institution","volume":"18","author":"Fields","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.det.2019.03.001_bib25","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2967\/jnumed.112.116814","article-title":"F-18-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience","volume":"54","author":"Siva","year":"2013","journal-title":"J\u00a0Nucl Med"},{"issue":"10","key":"10.1016\/j.det.2019.03.001_bib26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1524-4725.1997.tb00752.x","article-title":"Merkel cell carcinoma. comparison of Mohs micrographic surgery and wide excision in eighty-six patients","volume":"23","author":"O'Connor","year":"1997","journal-title":"Dermatol Surg"},{"issue":"8","key":"10.1016\/j.det.2019.03.001_bib27","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1842::AID-CNCR13>3.0.CO;2-P","article-title":"Merkel cell carcinoma - review of 22 cases with surgical, pathologic, and therapeutic considerations","volume":"88","author":"Gollard","year":"2000","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.det.2019.03.001_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaad.2018.01.041","article-title":"Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database","volume":"79","author":"Singh","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2019.03.001_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaad.2017.09.049","article-title":"Utilization patterns and survival outcomes after wide local excision or Mohs micrographic surgery for Merkel cell carcinoma in the United States, 2004-2009","volume":"78","author":"Shaikh","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2019.03.001_bib30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/DSS.0000000000000801","article-title":"Mohs micrographic surgery for the treatment of Merkel cell carcinoma","volume":"42","author":"Kline","year":"2016","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.det.2019.03.001_bib31","first-page":"165","article-title":"Merkel cell carcinoma of the skin and mucosa: report of 12 cutaneous cases with 2 cases arising from the nasal mucosa","volume":"27","author":"Snow","year":"2001","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.det.2019.03.001_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1067\/mjd.2002.125083","article-title":"Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation","volume":"47","author":"Boyer","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2019.03.001_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/000313481808400507","article-title":"Investigation of the diagnostic precision and utility of sentinel lymph node biopsy in the treatment of patients with Merkel cell carcinoma","volume":"84","author":"Lamb","year":"2018","journal-title":"Am Surg"},{"key":"10.1016\/j.det.2019.03.001_bib34","article-title":"Relative survival analysis in patients with stage I-II Merkel cell carcinoma treated with Mohs micrographic surgery or wide local excision","author":"Su","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.det.2019.03.001_bib35","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1245\/s10434-014-3757-8","article-title":"Outcomes of Merkel cell carcinoma treated with radiotherapy without radical surgical excision","volume":"21","author":"Harrington","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.det.2019.03.001_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ajd.12263","article-title":"Radiotherapy alone in patients with Merkel cell carcinoma: the Westmead Hospital experience of 41 patients","volume":"56","author":"Veness","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2019.03.001_bib37","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/annonc\/mdr318","article-title":"Adjuvant prophylactic regional radiotherapy versus observation in\u00a0stage I Merkel cell carcinoma: a multicentric prospective randomized study","volume":"23","author":"Jouary","year":"2012","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.det.2019.03.001_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw042","article-title":"Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: survival analyses of 6908 cases from the National Cancer Data Base","volume":"108","author":"Bhatia","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.det.2019.03.001_bib39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.adro.2016.10.003","article-title":"Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck","volume":"1","author":"Takagishi","year":"2016","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.det.2019.03.001_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamaoto.2014.3052","article-title":"The role of adjuvant therapy in the management of head and neck Merkel cell carcinoma an analysis of 4815 patients","volume":"141","author":"Chen","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.det.2019.03.001_bib41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1245\/s10434-015-4812-9","article-title":"Radiotherapy and conservative surgery in the locoregional management of Merkel cell carcinoma: the British Columbia Cancer Agency Experience","volume":"23","author":"Harrington","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.det.2019.03.001_bib42","first-page":"563829","article-title":"A\u00a0review of radiotherapy for Merkel cell carcinoma of the head and neck","volume":"2012","author":"Lee","year":"2012","journal-title":"J\u00a0Skin Cancer"},{"issue":"7","key":"10.1016\/j.det.2019.03.001_bib43","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/cncr.24919","article-title":"Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma","volume":"116","author":"Fang","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.det.2019.03.001_bib44","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/coa.12996","article-title":"Incurable, progressive Merkel cell carcinoma: a single-institution study of 54 cases","volume":"43","author":"Fochtmann-Frana","year":"2018","journal-title":"Clin Otolaryngol"},{"issue":"9","key":"10.1016\/j.det.2019.03.001_bib45","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","article-title":"Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma","volume":"5","author":"Iyer","year":"2016","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.det.2019.03.001_bib46","doi-asserted-by":"crossref","first-page":"782","DOI":"10.6004\/jnccn.2018.7049","article-title":"Advances in immunotherapy for metastatic Merkel cell carcinoma: a clinician's guide","volume":"16","author":"Paulson","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.det.2019.03.001_bib47","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/cup.12973","article-title":"PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma","volume":"44","author":"Mitteldorf","year":"2017","journal-title":"J\u00a0Cutan Pathol"},{"issue":"1","key":"10.1016\/j.det.2019.03.001_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40425-017-0310-x","article-title":"Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after\u00a0>\/=1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial","volume":"6","author":"Kaufman","year":"2018","journal-title":"J\u00a0Immunother Cancer"},{"issue":"9","key":"10.1016\/j.det.2019.03.001_bib49","doi-asserted-by":"crossref","first-page":"e180077","DOI":"10.1001\/jamaoncol.2018.0077","article-title":"Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma: a preplanned interim analysis of a clinical trial","volume":"4","author":"D'Angelo","year":"2018","journal-title":"JAMA Oncol"},{"issue":"13 Suppl","key":"10.1016\/j.det.2019.03.001_bib50","doi-asserted-by":"crossref","first-page":"CT074","DOI":"10.1158\/1538-7445.AM2017-CT074","article-title":"Abstract CT074: non-comparative, open-label, multiple cohort, phase 1\/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): efficacy and safety in Merkel cell carcinoma (MCC)","volume":"77","author":"Topalian","year":"2017","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.det.2019.03.001_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2217\/fon-2017-0470","article-title":"Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma","volume":"14","author":"Kaufman","year":"2018","journal-title":"Future Oncol"},{"issue":"1","key":"10.1016\/j.det.2019.03.001_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/2326-6066.CIR-13-0087","article-title":"Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I","volume":"2","author":"Chapuis","year":"2014","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"10.1016\/j.det.2019.03.001_bib53","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.3747\/co.23.2878","article-title":"Immunotherapy with imiquimod and interferon alfa for metastasized Merkel cell carcinoma","volume":"23","author":"Wahl","year":"2016","journal-title":"Curr Oncol"},{"issue":"Suppl 15","key":"10.1016\/j.det.2019.03.001_bib54","article-title":"Augmentation of adoptive T-cell therapy for Merkel cell carcinoma with avelumab","volume":"35","author":"Paulson","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.det.2019.03.001_bib55","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archderm.1989.01670200069011","article-title":"Merkel cell carcinoma. A successful treatment with tumor necrosis factor","volume":"125","author":"Ito","year":"1989","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2019.03.001_bib56","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00006534-199702000-00038","article-title":"Two cases of Merkel cell carcinoma cured by intratumor injection of natural human tumor necrosis factor","volume":"99","author":"Hata","year":"1997","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.det.2019.03.001_bib57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2133.1991.tb00642.x","article-title":"Treatment of Merkel cell tumor with interferon-alpha-2b","volume":"124","author":"Durand","year":"1991","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2019.03.001_bib58","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/0284186X.2010.512924","article-title":"Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus","volume":"50","author":"Biver-Dalle","year":"2011","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.det.2019.03.001_bib59","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1158\/2326-6066.CIR-14-0005","article-title":"Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma","volume":"2","author":"Paulson","year":"2014","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"10.1016\/j.det.2019.03.001_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jdcr.2017.02.003","article-title":"Talimogene laherparepvec for regionally advanced Merkel cell carcinoma: a report of 2 cases","volume":"3","author":"Blackmon","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.det.2019.03.001_bib61","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/1078-0432.CCR-18-0469","article-title":"Intratumoral G100, a TLR4 agonist, induces anti-tumor immune responses and tumor regression in patients with Merkel cell carcinoma","volume":"25","author":"Bhatia","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.det.2019.03.001_bib62","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S0959-8049(16)30306-9","article-title":"Intratumoral delivery of Interleukin-12 DNA via in\u00a0vivo electroporation leads to regression of injected and non-injected tumors in Merkel cell carcinoma: final results of a phase 2 study","volume":"51","author":"Bhatia","year":"2015","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.det.2019.03.001_bib63","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMc1507446","article-title":"Response to idelalisib in a patient with stage IV Merkel cell carcinoma","volume":"373","author":"Shiver","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.det.2019.03.001_bib64","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1200\/JCO.2016.34.15_suppl.9542","article-title":"UKMCC-01: a phase II study of pazopanib (PAZ) in metastatic Merkel cell carcinoma","volume":"34","author":"Nathan","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.det.2019.03.001_bib65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.12659\/AJCR.908649","article-title":"Clinical benefit from tyrosine kinase inhibitors in metastatic Merkel cell carcinoma: a case series of 5 patients","volume":"19","author":"Tarabadkar","year":"2018","journal-title":"Am J Case Rep"},{"issue":"3","key":"10.1016\/j.det.2019.03.001_bib66","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4103\/0973-1482.73352","article-title":"Remission of Merkel cell tumor after somatostatin analog treatment","volume":"6","author":"Fakiha","year":"2010","journal-title":"J\u00a0Cancer Res Ther"},{"issue":"9","key":"10.1016\/j.det.2019.03.001_bib67","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jamadermatol.2016.1428","article-title":"Recurrence and survival in patients with Merkel cell carcinoma undergoing surgery without adjuvant radiation therapy to the primary site","volume":"152","author":"Frohm","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"21","key":"10.1016\/j.det.2019.03.001_bib68","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1158\/0008-5472.CAN-10-2128","article-title":"Antibodies to Merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients","volume":"70","author":"Paulson","year":"2010","journal-title":"Cancer Res"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863519300208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863519300208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:43:49Z","timestamp":1760006629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863519300208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0733863519300208"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2019.03.001","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Merkel Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}